Novo Nordisk A/S (NOV.DE)

EUR 103.14

(-0.33%)

Total Assets Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual total assets in 2023 was 42.17 Billion DKK , up 30.38% from previous year.
  • Novo Nordisk A/S's latest quarterly total assets in 2024 Q1 was 39.97 Billion DKK , down -4.95% from previous quarter.
  • Novo Nordisk A/S reported annual total assets of 32.34 Billion DKK in 2022, up 23.68% from previous year.
  • Novo Nordisk A/S reported annual total assets of 26.15 Billion DKK in 2021, up 34.33% from previous year.
  • Novo Nordisk A/S reported quarterly total assets of 39.97 Billion DKK for 2024 Q1, down -4.95% from previous quarter.
  • Novo Nordisk A/S reported quarterly total assets of 42.17 Billion DKK for 2023 FY, up 30.38% from previous quarter.

Annual Total Assets Chart of Novo Nordisk A/S (2023 - 2016)

Historical Annual Total Assets of Novo Nordisk A/S (2023 - 2016)

Year Total Assets Total Assets Growth
2023 42.17 Billion DKK 30.38%
2022 32.34 Billion DKK 23.68%
2021 26.15 Billion DKK 34.33%
2020 19.46 Billion DKK 15.82%
2019 16.8 Billion EUR 13.25%
2018 14.84 Billion EUR 7.97%
2017 13.74 Billion EUR 4.8%
2016 13.11 Billion EUR 0.0%

Peer Total Assets Comparison of Novo Nordisk A/S

Name Total Assets Total Assets Difference
BioNTech SE 23 Billion EUR -83.323%
CureVac N.V. 788.89 Million EUR -5246.165%
Biotest Aktiengesellschaft 1.44 Billion EUR -2820.158%
Biotest Aktiengesellschaft 1.44 Billion EUR -2820.158%
BRAIN Biotech AG 70.93 Million EUR -59355.347%
Formycon AG 890.36 Million EUR -4636.932%
Heidelberg Pharma AG 70.35 Million EUR -59848.858%
Medigene AG 31.71 Million EUR -132879.693%